Anavex Life Sciences to Present at the H.C. Wainwright Annual Global Life Sciences Conference

Anavex Life Sciences to Present at the H.C. Wainwright Annual Global Life Sciences Conference   NEW YORK – April 5, 2019 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and…